CANCER OF ESOPHAGUS
Clinical trials for CANCER OF ESOPHAGUS explained in plain language.
Never miss a new study
Get alerted when new CANCER OF ESOPHAGUS trials appear
Sign up with your email to follow new studies for CANCER OF ESOPHAGUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for Hard-to-Treat stomach cancer
Disease control CompletedThis study tested a two-step treatment for people with advanced stomach or esophageal cancer that has a specific genetic change (MGMT deficiency) and has not responded to standard chemotherapy. First, patients received a drug called temozolomide to prime the tumor, followed by th…
Matched conditions: CANCER OF ESOPHAGUS
Phase: PHASE2 • Sponsor: University of Southampton • Aim: Disease control
Last updated May 26, 2026 05:15 UTC
-
Could a common ED drug boost cancer immunotherapy?
Disease control CompletedThis study tested whether adding tadalafil (a drug often used for erectile dysfunction) to pembrolizumab (an immunotherapy) could help control advanced head and neck cancer. Seven adults with recurrent or metastatic disease participated. The goal was to check safety and see if th…
Matched conditions: CANCER OF ESOPHAGUS
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 26, 2026 05:08 UTC
-
Step counts predict hospital risk in cancer patients
Symptom relief CompletedThis study tested whether monitoring daily steps with a pedometer could help identify cancer patients at high risk of hospitalization during chemoradiotherapy. 40 adults with head and neck, lung, esophagus, or stomach cancer participated. When step counts dropped, a rapid support…
Matched conditions: CANCER OF ESOPHAGUS
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC